Alnylam Pharmaceuticals Inc (ALNY)

245.50 +6.63 (+2.78%) USD  |  NASDAQ  |  Dec 20, 16:00
245.46 -0.04 (-0.02%) After-Hours: 20:00
More

Alnylam Pharmaceuticals Return on Net Operating Assets

Return on Net Operating Assets Chart

View Return on Net Operating Assets for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Return on Net Operating Assets Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Return on Net Operating Assets Range, Past 5 Years

View Return on Net Operating Assets Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Return on Net Operating Assets Benchmarks

View Return on Net Operating Assets Benchmarks
Start Trial
Pfizer Inc Upgrade
BridgeBio Pharma Inc Upgrade
Gilead Sciences Inc Upgrade
Regeneron Pharmaceuticals Inc Upgrade
Sarepta Therapeutics Inc Upgrade

Return on Net Operating Assets Related Metrics

Return on Assets Upgrade
Return on Invested Capital Upgrade
Profit Margin (Quarterly) Upgrade
Gross Profit Margin (Quarterly) Upgrade
Operating Margin (Quarterly) Upgrade